MONTREAL, Oct. 19 /CNW Telbec/ - (TSX.V: BUG) - Biophage Pharma Inc.
(Biophage) today announced that based on its advanced stage of development of
the PDS(R) biosensor, it is now preparing itself for regulatory compliance as
it starts the process of bringing this product to market as a new medical
device for the detection of bacterial contamination in blood and biological
fluids.
